small plant in large empty pot
Photo: Marta Nogueira / Pexels

UpTrajectory Review

Adam Job distills findings from a study of more than 600 publicly traded U.S. companies into three patterns: firms that convert AI spending into shareholder returns share common traits in how they deploy, govern, and scale the technology. The piece promises evidence, not anecdotes, which distinguishes it from much AI commentary. Job writes for HBR, where the audience skews toward enterprise strategy, but the underlying question — when does technology spending actually pay back? — applies at every scale. The study's scope matters: 600 companies is large enough to separate correlation from luck, and the shareholder-return lens forces a discipline that most AI discussions avoid. Returns are measured, not promised.

For a small-business operator, the signal matters more than the stock-price framing. Public companies face pressure to show returns within quarters; owners face the same pressure without the cushion of investor capital or a communications team to spin slow progress. The study's value lies in what it reveals about sequencing: which AI uses produce measurable results first, and which drain budget while promising future magic. A five-person shop that automates invoicing or customer intake can see payoff in weeks. A five-person shop that buys an enterprise AI platform to 'transform operations' usually sees confusion. The framing helps owners ask sharper questions before they spend.

The three-way framing is tidy, perhaps too tidy. Academic categorization often smooths the messiness of real adoption, where a single customer-service chatbot might span all three patterns at once. We would treat the taxonomy as a diagnostic lens, not a playbook. The genuinely useful question the piece raises: are you deploying AI to cut costs, to grow revenue, or to build capability — and does your spending match your stated priority? Most owners we know cannot answer that cleanly. They buy tools reactively, under pressure from vendors or competitors, and discover the purpose afterward. That is backwards, and it is expensive.

Second-order effects cut in both directions. Large firms with dedicated AI teams can absorb failed experiments; small firms cannot. Yet small firms often move faster once they commit, because fewer stakeholders must align and the owner can authorize change in an afternoon. The risk for owners is not falling behind on technology but spending ahead of operational maturity — buying capability that the business process cannot yet absorb. A poorly documented workflow does not improve when you add AI; it fails faster. Owners should also watch how public-company patterns shape vendor pricing and feature roadmaps, because enterprise demand pulls the market in directions that may not serve smaller buyers.

Watch for follow-up research that tracks whether these returns persist beyond the initial efficiency gains. Early AI wins often come from automating existing work; sustained returns require redesigning the work itself. That distinction will separate durable advantage from one-time savings, and it is where most small businesses stall. The first win is easy to measure. The second requires changing how the business operates, which is harder and slower. Owners who treat AI as a procurement decision will plateau; owners who treat it as an operations redesign will compound.

Practical step this week: audit your last three AI-related expenditures. Label each as cost reduction, revenue enablement, or capability building. If the labels do not match your strategic intent, the spending will not either. Share the audit with whoever manages your books, and set a thirty-day checkpoint to measure what changed. If nothing measurable changed, stop spending and fix the process first. The study's lesson applies at every scale: returns come from alignment, not volume.

Takeaway: Audit your last three AI expenditures and label each as cost reduction, revenue enablement, or capability building; mismatched spending never returns value.

Excerpt from the original — Harvard Business Review

<p>Lessons from a study of more than 600 publicly traded U.S. companies.</p>